NEW YORK, Dec 13 - Amersham Pharmacia Biotech has introduced a new high-performance multiple capillary DNA analysis system, the company announced Wednesday.

The new MegaBACE 500 system builds on technology developed for the company’s MegaBACE 1000 system, its first commercially available multiple capillary sequencer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.